Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 2 (2005), Issue 1 (January)

1. The use of placebo in clinical trials on bipolar disorder: a new approach for an old debate.
   Psychother Psychosom, 74(1): 10-6. [Abstract] [Full-text]
2. Neurocognitive impairment in euthymic patients with bipolar affective disorder.
   Br J Psychiatry, 186: 32-40. [Abstract] [Full-text]
3. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
   Arch Gen Psychiatry, 62(1): 37-45. [Abstract] [Full-text]
4. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression.
   Neuron, 45(1): 11-6. [Abstract] [Full-text]
5. B56 regulatory subunit of protein phosphatase 2A mediates valproic acid-induced p300 degradation.
   Mol Cell Biol, 25(2): 525-32. [Abstract] [Full-text]
6. Genomewide scan for affective disorder susceptibility Loci in families of a northern Swedish isolated population.
   Am J Hum Genet, 76(2): 237-48. [Abstract] [Full-text]
7. The treatment gap in mental health care.
   Bull World Health Organ, 82(11): 858-66. [Abstract] [Full-text]
8. Distinguishing bipolar depression, major depression, and schizophrenia with the MMPI-2 clinical and content scales.
   J Pers Assess, 84(1): 89-95. [Abstract] [Full-text]
9. Mania and dysregulation in goal pursuit: a review.
   Clin Psychol Rev, 25(2): 241-62. [Abstract] [Full-text]
10. Oral lichenoid drug reaction by lithium in a patient with bipolar disorder.
    J Oral Pathol Med, 34(2): 124-6. [Abstract] [Full-text]
11. Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment.
    Pharmacogenomics J, 5(1): 35-41. [Abstract] [Full-text]
12. Sustained attention-deficit confirmed in euthymic bipolar disorder but not in first-degree relatives of bipolar patients or euthymic unipolar depression.
    Biol Psychiatry, 57(2): 183-7. [Abstract] [Full-text]
13. Effects of adjunctive mifepristone (RU-486) administration on neurocognitive function and symptoms in schizophrenia.
    Biol Psychiatry, 57(2): 155-61. [Abstract] [Full-text]
14. Postictal mania associated with frontal lobe epilepsy.
    Epilepsy Behav, 6(1): 102-10. [Abstract] [Full-text]
15. Dark therapy for mania: a pilot study.
    Bipolar Disord, 7(1): 98-101. [Abstract] [Full-text]
16. Clinical, psychosocial, and treatment differences in minority patients with bipolar disorder.
    Bipolar Disord, 7(1): 89-97. [Abstract] [Full-text]
17. African-American participants in a bipolar disorder registry: clinical and treatment characteristics.
    Bipolar Disord, 7(1): 82-8. [Abstract] [Full-text]
18. Increased risk for pulmonary embolism in patients with bipolar disorder.
    Bipolar Disord, 7(1): 77-81. [Abstract] [Full-text]
19. Recovery and functional outcomes following olanzapine treatment for bipolar I mania.
    Bipolar Disord, 7(1): 68-76. [Abstract] [Full-text]
20. Neuropsychological deficits in adolescents with conduct disorder and comorbid bipolar disorder: a pilot study.
    Bipolar Disord, 7(1): 57-67. [Abstract] [Full-text]
21. Content-specificity of dysfunctional cognitions for patients with bipolar mania versus unipolar depression: a preliminary study.
    Bipolar Disord, 7(1): 49-56. [Abstract] [Full-text]
22. Interaction of calbindin D28k and inositol monophosphatase in human postmortem cortex: possible implications for bipolar disorder.
    Bipolar Disord, 7(1): 42-8. [Abstract] [Full-text]
23. Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons.
    Bipolar Disord, 7(1): 33-41. [Abstract] [Full-text]
24. Psychological therapies for bipolar disorder: the role of model-driven approaches to therapy integration.
    Bipolar Disord, 7(1): 22-32. [Abstract] [Full-text]
25. Bipolar II disorder: a review.
    Bipolar Disord, 7(1): 11-21. [Abstract] [Full-text]
26. Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings.
    Bipolar Disord, 7(1): 1-10. [Abstract] [Full-text]
27. Association study of the frizzled-3 (FZD3) gene with schizophrenia and mood disorders.
    J Neural Transm, 112(2): 303-7. [Abstract] [Full-text]
28. Medical comorbidity in a bipolar outpatient clinical population.
    Neuropsychopharmacology, 30(2): 401-4. [Abstract] [Full-text]
29. T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients.
    Psychiatry Res, 129(3): 267-72. [Abstract] [Full-text]
30. Association and linkage analysis of RGS4 polymorphisms with schizophrenia and bipolar disorder in Brazil.
    Genes Brain Behav, 4(1): 45-50. [Abstract] [Full-text]
31. Attention and memory biases in the offspring of parents with bipolar disorder: indications from a pilot study.
    J Child Psychol Psychiatry, 46(1): 84-93. [Abstract] [Full-text]
32. Clinical value of 99mTc-HMPAO SPECT in depressed bipolar I patients.
    Psychiatry Res, 132(3): 285-9. [Abstract] [Full-text]
33. Nonlinear analysis of RR interval in euthymic bipolar disorder.
    Auton Neurosci, 117(2): 127-31. [Abstract] [Full-text]
34. A form of DISC1 enriched in nucleus: altered subcellular distribution in orbitofrontal cortex in psychosis and substance/alcohol abuse.
    Proc Natl Acad Sci U S A, 102(4): 1187-92. [Abstract] [Full-text]
35. Suicidal behavior: relationship between phenotype and serotonergic genotype.
    Am J Med Genet C Semin Med Genet, 133(1): 25-33. [Abstract] [Full-text]
36. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report.
    Am J Med Genet B Neuropsychiatr Genet, 133(1): 1-5. [Abstract] [Full-text]
37. Linkage disequilibrium analysis in the LOC93081-KDELC1-BIVM region on 13q in bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet, 133(1): 12-7. [Abstract] [Full-text]
38. Structural variants in the retinoid receptor genes in patients with schizophrenia and other psychiatric diseases.
    Am J Med Genet B Neuropsychiatr Genet, 133(1): 50-3. [Abstract] [Full-text]
39. Family history influences age of onset in bipolar I disorder in females but not in males.
    Am J Med Genet B Neuropsychiatr Genet, 133(1): 6-11. [Abstract] [Full-text]
40. Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders.
    Am J Med Genet B Neuropsychiatr Genet, 133(1): 110-5. [Abstract] [Full-text]
41. Joint multi-population analysis for genetic linkage of bipolar disorder or "wellness" to chromosome 4p.
    Am J Med Genet B Neuropsychiatr Genet, 133(1): 18-24. [Abstract] [Full-text]
42. A genome-wide search for risk genes using homozygosity mapping and microarrays with 1,494 single-nucleotide polymorphisms in 22 eastern Cuban families with bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet, 133(1): 25-30. [Abstract] [Full-text]
43. Psychiatric and medical comorbidities of bipolar disorder.
    Psychosom Med, 67(1): 1-8. [Abstract] [Full-text]
44. BDNF gene is a risk factor for schizophrenia in a Scottish population.
    Mol Psychiatry, 10(2): 208-12. [Abstract] [Full-text]
45. MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders.
    Mol Psychiatry, 10(2): 160-84. [Abstract] [Full-text]
46. Prevalence and risk factors for homelessness and utilization of mental health services among 10,340 patients with serious mental illness in a large public mental health system.
    Am J Psychiatry, 162(2): 370-6. [Abstract] [Full-text]
47. Relapse prevention in patients with bipolar disorder: cognitive therapy outcome after 2 years.
    Am J Psychiatry, 162(2): 324-9. [Abstract] [Full-text]
48. Mental health service delivery and suicide risk: the role of individual patient and facility factors.
    Am J Psychiatry, 162(2): 311-8. [Abstract] [Full-text]
49. Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England.
    Am J Psychiatry, 162(2): 257-62. [Abstract] [Full-text]
50. Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania.
    Behav Brain Res, 158(1): 123-32. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.